Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02595502 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 286
- Enrollment target
NCT02595502: Completed NA study, sponsored by Johnson & Johnson Vision Care.
NCT02595502 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 286 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02595502, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 286 participants
- Enrollment target
Study Summary
The purpose of this investigation is to evaluate the short-term, clinical performance of two silicone hydrogel daily disposable contact lenses.
Primary Outcome
Overall comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/po
Interventions
- DEVICE JJVC Marketed Contact Lens (Test)
- DEVICE Competitor Marketed Contact Lens (Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 286 participants |
| Start Date | 2015-09-01 |
| Est. Completion | 2015-11-01 |
| Phase | NA |
What the finished NCT02595502 record still lists
NCT02595502 is an interventional study that assigns participants to a tested intervention. The registered 286 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which JJVC Marketed Contact Lens (Test) is the first listed.
NCT02595502 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02595502 about?
NCT02595502 is a clinical study titled "Clinical Evaluation of Two Silicone Hydrogel Daily Disposable Contact Lenses". The purpose of this investigation is to evaluate the short-term, clinical performance of two silicone hydrogel daily disposable contact lenses.
What is the current status of trial NCT02595502?
This trial is currently completed. It is a NA study. The enrollment target is 286 participants. The study started on 2015-09-01. Estimated completion is 2015-11-01.
What interventions are being tested in trial NCT02595502?
The interventions under investigation include: JJVC Marketed Contact Lens (Test) (DEVICE), Competitor Marketed Contact Lens (Control) (DEVICE).
Who is sponsoring clinical trial NCT02595502?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02595502's enrollment target sits among peer trials
286 377th of 2000 higher than 1,624 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04781140 · 286 participants · Phase 4
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- NCT04936529 · 286 participants · Phase 2
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
- NCT05183646 · 286 participants · Phase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- NCT05506878 · 286 participants · NA
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI